Victory Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2K | Buy |
+12,435
| New | +$28.2K | ﹤0.01% | 2420 |
|
|
2021
Q4 | – | Sell |
-3,269,112
| Closed | -$16.6M | – | 2790 |
|
|
2021
Q3 | $16.6M | Buy |
3,269,112
+400,126
| +14% | +$2.04M | 0.02% | 954 |
|
|
2021
Q2 | $18.2M | Buy |
2,868,986
+100,104
| +4% | +$634K | 0.02% | 935 |
|
|
2021
Q1 | $21.4M | Buy |
2,768,882
+451,485
| +19% | +$3.49M | 0.02% | 885 |
|
|
2020
Q4 | $15.2M | Sell |
2,317,397
-110,409
| -5% | -$723K | 0.02% | 983 |
|
|
2020
Q3 | $16.1M | Buy |
2,427,806
+150,846
| +7% | +$1M | 0.02% | 890 |
|
|
2020
Q2 | $19M | Sell |
2,276,960
-3,267,892
| -59% | -$27.2M | 0.03% | 805 |
|
|
2020
Q1 | $42.5M | Buy |
5,544,852
+2,731,401
| +97% | +$21M | 0.04% | 631 |
|
|
2019
Q4 | $23.4M | Buy |
2,813,451
+191,329
| +7% | +$1.59M | 0.03% | 769 |
|
|
2019
Q3 | $19.4M | Buy |
2,622,122
+636,132
| +32% | +$4.69M | 0.02% | 804 |
|
|
2019
Q2 | $22.3M | Buy |
1,985,990
+330,460
| +20% | +$3.71M | 0.04% | 576 |
|
|
2019
Q1 | $17.8M | Buy |
1,655,530
+735,320
| +80% | +$7.9M | 0.04% | 596 |
|
|
2018
Q4 | $13.9M | Buy |
920,210
+29,810
| +3% | +$450K | 0.03% | 640 |
|
|
2018
Q3 | $16.5M | Buy |
890,400
+773,080
| +659% | +$14.3M | 0.03% | 656 |
|
|
2018
Q2 | $2.68M | Sell |
117,320
-6,710
| -5% | -$153K | 0.01% | 1010 |
|
|
2018
Q1 | $3.53M | Buy |
+124,030
| New | +$3.53M | 0.01% | 903 |
|